Health
New antiviral repurposing study finds peptides that could prevent SARS-CoV-2-ACE2 binding – News-Medical.Net
A new study reports the antiviral potential of peptides against SARS-CoV-2’s spike protein.
As the world continues to struggle with the coronavirus disease 2019 (COVID-19) pandemic, researchers are busy searching for pharmaceuticals that can effectively counteract the pathogen. This causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infects through engagement via its spike protein with the host cell, attaching to the angiotensin-converting enzyme 2 (ACE2) receptor. The spike-ACE2 interaction has thus become a prime target of antiviral strategies.
A new study…
-
General21 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business17 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News6 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth